SCHEMBL25580765

SCHEMBL25580765

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2-c2ccc(N(c3cccc(-c4ccc5ccccc5c4)c3)c3cccc(-n4c5ccccc5c5ccccc54)c3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HSD17B1 P14061 2/20 0.32
HSD17B2 P37059 2/20 0.32
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31
TUBB3 Q13509 1/20 0.31
TUBB2A Q13885 1/20 0.31
TUBB8 Q3ZCM7 1/20 0.31
TUBA3E Q6PEY2 1/20 0.31
TUBA1A Q71U36 1/20 0.31
TUBA1C Q9BQE3 1/20 0.31
TUBB6 Q9BUF5 1/20 0.31
TUBB2B Q9BVA1 1/20 0.31
TUBB1 Q9H4B7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580906 0.98 KDM4E (0.33) KDM4EATML3MBTL1HSD17B1HSD17B2
SCHEMBL25580617 0.98 KDM4E (0.35) KDM4EATML3MBTL1HSD17B1HSD17B2
SCHEMBL25581032 0.97 KDM4E (0.35) KDM4EATML3MBTL1HSD17B1HSD17B2
SCHEMBL25580668 0.96 KDM4E (0.36) KDM4EATML3MBTL1
SCHEMBL25580756 0.95 KDM4E (0.35) KDM4EATML3MBTL1HSD17B1HSD17B2
SCHEMBL25580753 0.94 KDM4E (0.36) KDM4EATML3MBTL1HSD17B1HSD17B2
SCHEMBL25581025 0.94 KDM4E (0.35) KDM4EATML3MBTL1HSD17B1HSD17B2
SCHEMBL25580950 0.94 KDM4E (0.36) KDM4EATML3MBTL1
SCHEMBL25580606 0.93 KDM4E (0.35) KDM4EATML3MBTL1
SCHEMBL25580893 0.93 KDM4E (0.34) KDM4EATML3MBTL1HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 KDM4E 2752/4885ATM 2320/4885L3MBTL1 148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.